In vitro comparison of output and particle size distribution of budesonide from metered-dose inhaler with three spacer devices during pediatric tidal breathing

Treatments in Respiratory Medicine

Volumn 5, Issue 6, 2006, Pages 503-508

  Kamin, Wolfgang ^a,c   Ehlich, Hilke ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Inamed Research GmbH and Co KG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; BRONCHODILATING AGENT;

ARTICLE; BREATHING DISORDER; CONTROLLED STUDY; DEVICE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METERED DOSE INHALER; PARTICLE SIZE; PRESCHOOL CHILD; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; ASTHMA; CHILD; IN VITRO STUDY; INHALATIONAL DRUG ADMINISTRATION; NEBULIZER;

ADMINISTRATION, INHALATION; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD; HUMANS; IN VITRO TECHNIQUES; METERED DOSE INHALERS; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE;

EID: 33845701748     PISSN: 11763450     EISSN: 11763450     Source Type: Journal    
DOI: 10.2165/00151829-200605060-00013     Document Type: Article

References (27)

1. Ross DL, Schultz RK. Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products. J Aerosol Med 1996; 9: 215-26
2. Smith KJ, Chan HK, Brown KF. Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers. J Aerosol Med 1998; 11: 231-45
3. Everard ML, Devadason SG, LeSouéf PN. Flow early in the inspiratory maneuver affects the aerosol particle size distribution from a Turbohaler. Respir Med 1997; 91: 624-8
4. Leach CL. Improved delivery of inhaled steroids to the large and small airways. Respir Med 1998; 92: 3-8s
5. Feddah MR, Davies NM, Gipps EM, et al. Influence of respiratory spacer devices on aerodynamic particle size distribution and fine particle mass of beclomethasone from metered-dose inhalers. J Aerosol Med 2001; 14: 477-85
6. Asmus MJ, Liang J, Coowanitwong I, et al. In vitro performance characteristics of valved holding chamber and spacer devices with a fluticasone metered-dose inhaler. Pharmacotherapy 2004; 24: 159-66
7. Terzano C, Mannino F. Aerosol characterization of three corticosteroid metered dose inhalers with volumatic holding chambers and metered dose inhalers alone at two inspiratory flow rates. J Aerosol Med 1999; 12: 249-54
8. Janssens HM, Krijgsman A, Verbraak TFM, et al. Determining factors of aerosol deposition for four pMDI-Spacer combinations in an infant upper airway model. J Aerosol Med 2004; 17: 51-61
9. Everard ML, Clark AR, Milner AD. Drug delivery from holding chambers with attached facemask. Arch Dis Child 1992; 67: 580-5
10. Mitchell JP, Nagel MW. In vitro performance testing of three small volume-holding chambers under conditions that correspond with use by infants and small children. J Aerosol Med 1997; 10: 341-9
11. Berg E, Madsen J, Bisgaard H. In vitro performance of three combinations of spacers and pressurized metered dose inhalers for treatment in children. Eur Respir J 1998; 12: 472-6
12. Finlay WH, Zuberbuhler P. In vitro comparison of beclomethasone and salbutamol metered-dose inhaler aerosols inhaled during pediatric tidal breathing from four valved holding chambers. Chest 1998; 114: 1676-80
13. Barry PW, O'Callaghan C. The output of budesonide from spacer devices assessed under simulated breathing conditions. J Allergy Clin Immunol 1999; 104: 1205-10
14. Janssens HM, De Jongste JC, Hop WC, et al. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model. Chest 2003; 123: 2083-8
15. Usmani OS, Biddiscombe MF, Nightingale JA, et al. Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols. J Appl Physiol 2003; 95: 2106-12
16. Ganderton D, Lewis D, Davies R, et al. The formulation and evaluation of CFC-free budesonide pressurized metered dose inhaler. Respir Med 2003; Suppl. D: S4-9
17. US Pharmacopeia. Physical tests and determinations: aerosols. Rockville (MD): United States Pharmacopeia, USP Convention Inc., 2nd Supplement 2003; chapter 601: 2105-23
18. Berg E, Asking L, Svensson JO. Is it possible to measure the particle size distribution from a pMDI/spacer during simulated breathing? Eur Respir J 1997; 10: 81s
19. O'Callaghan C, Lynch J, Robertson C. Improvement in sodium chromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax 1993; 48: 603-6
20. Council of Europe. Preparations for inhalation: aerodynamic assessment of fine particles. European Pharmacopoeia 2002, Council of Europe, Strasbourg, France. 3rd Supplement 2001: 113-24
21. Kenyon CJ, Thorsson L, Borgström L, et al. The effects of static charge in spacer devices on glucocorticosteroid aerosol deposition in asthmatic patients. Eur Respir J 1998; 11: 606-10
22. Pierart F, Wildhaber JH, Vrancken I, et al. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J 1999; 13: 673-8
23. Janssens HM, Devadason SG, Hop WC, et al. Variability of aerosol delivery via spacer devices in young asthmatic children in daily life. Eur Respir J 1999; 13: 787-91
24. Turpeinen M, Nikander K, Malmberg LP, et al. Metered dose inhaler add-on devices: is the inhaled mass of drug dependent on the size of the infant? J Aerosol Med 1999; 12: 171-6
25. Thorsson L, Edsbacker S. Lung deposition of budesonide from a pressurized metered-dose inhaler attached to a spacer. Eur Resp J 1998; 12: 1340-5
26. Onhoj J, Thorsson L, Bisgaard H. Lung deposition of inhaled drugs increases with age. Am J Respir Crit Care Med 2000; 162: 1819-22
27. Janssens HM, Heijnen EM, de Jong VM, et al. Aerosol delivery from spacers in wheezy infants: a daily life study. Eur Respir J 2000; 16: 850-6